Longboard Pharmaceuticals, Inc. (LBPH)
NASDAQ: LBPH · Real-Time Price · USD
59.76
+0.01 (0.02%)
Nov 19, 2024, 1:15 PM EST - Market open
Longboard Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 20.19 | 13.01 | 10.16 | 8.07 | 2.37 |
| Research & Development | 67.26 | 43.75 | 34.64 | 19.77 | 4.63 |
| Operating Expenses | 87.45 | 56.76 | 44.8 | 27.84 | 7 |
| Operating Income | -87.45 | -56.76 | -44.8 | -27.84 | -7 |
| Interest & Investment Income | 11.26 | 2.41 | 0.84 | 0.06 | - |
| Other Non Operating Income (Expenses) | -0.15 | -0.07 | 0.02 | -0.02 | - |
| EBT Excluding Unusual Items | -76.34 | -54.42 | -43.95 | -27.8 | -7 |
| Other Unusual Items | - | - | - | - | -7.4 |
| Pretax Income | -76.34 | -54.42 | -43.95 | -27.8 | -14.4 |
| Net Income | -76.34 | -54.42 | -43.95 | -27.8 | -14.4 |
| Net Income to Common | -76.34 | -54.42 | -43.95 | -27.8 | -14.4 |
| Shares Outstanding (Basic) | 34 | 23 | 17 | 14 | 4 |
| Shares Outstanding (Diluted) | 34 | 23 | 17 | 14 | 4 |
| Shares Change (YoY) | 63.09% | 32.51% | 19.02% | 278.34% | - |
| EPS (Basic) | -2.23 | -2.39 | -2.56 | -1.93 | -3.78 |
| EPS (Diluted) | -2.23 | -2.39 | -2.56 | -1.93 | -3.78 |
| Free Cash Flow | -65.93 | -50.87 | -38.06 | -24.72 | -3.44 |
| Free Cash Flow Per Share | -1.92 | -2.24 | -2.22 | -1.72 | -0.90 |
| EBITDA | -87.45 | -56.75 | -44.79 | -27.84 | - |
| D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0 | - |
| EBIT | -87.45 | -56.76 | -44.8 | -27.84 | -7 |
Source: S&P Capital IQ. Standard template.
Financial Sources.